Valuation (17%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -17.40 | 8.96 |
| PEG Ratio (TTM) | -0.74 | -3.93 |
| P/S Ratio (TTM) | 0.37 | 3.46 |
| P/B Ratio (TTM) | 2.77 | 2.15 |
| P/FCF Ratio (TTM) | -4.32 | 20.91 |
| Price to 5YR AVG Earnings Ratio | N/A | 21.71 |
| Price to 5YR AVG FCF Ratio | N/A | 26.58 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -2.38% | 2.25% |
| ROE (TTM) | -14.38% | 13.48% |
| Net Profit Margin (TTM) | -2.05% | -49.59% |
| ROIC 5YR AVG | N/A | 1.03% |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 558.08% | 7.12% | N/A |
| Revenue | 1.52% | 8.35% | N/A |
| Net Income | 559.49% | 10.72% | N/A |
| Cash Flow | -15.46% | 134.77% | N/A |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.26 | 2.36 |
| Quick Ratio (TTM) | 0.41 | 1.70 |
| D/E Ratio (TTM) | 0.60 | 0.79 |
| Interest Coverage (TTM) | 0.78 | -23.15 |
| Piotroski F-Score | N/A | 6 |
| Altman Z-Score | 0.31 | 4.47 |
| LTL to 5YR AVG FCF | N/A | 8.41 |
| Shares Outstanding Growth 5YR AVG | N/A | 12.67% |